hasTargetDisease
P20980
predicate
Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
All labels observed (20)
| Label | Occurrences |
|---|---|
| therapeuticArea | 219 |
| hasTherapeuticArea | 67 |
| targetsDisease | 20 |
| targetDisease | 18 |
| studiesDisease | 8 |
| diseaseArea | 6 |
| therapeuticTargetIn | 5 |
| surveillanceFocusDiseases | 4 |
| diseaseTarget | 3 |
| diseaseTargeted | 2 |
| hasFocusDisease | 2 |
| treatsDiseaseArea | 2 |
| actsOnDisease | 1 |
| combinedWithFlucytosineUsedFor | 1 |
| coveredDisease | 1 |
| diseaseBurdenAddressed | 1 |
| hasFDAIndicationText | 1 |
| hasPrimaryDiseaseFocus | 1 |
| hasTargetDisease canonical | 1 |
| relatedToDisease | 1 |
Description generation (PDg)
The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.
Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning. # Instructions Focus on describing the relationship, not the entities themselves. # Response Format Begin the description with \' Indicates...\'
Input
Predicate: hasTargetDisease
Generated description
Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
Sample triples (364)
| Subject | Object |
|---|---|
| fam-trastuzumab deruxtecan | oncology via predicate surface "hasTherapeuticArea" ⓘ |
|
mosunetuzumab (bispecific antibody component)
surface form:
mosunetuzumab
|
hematologic oncology via predicate surface "therapeuticArea" ⓘ |
|
CLinical Evaluation Of Pertuzumab And TRAstuzumab
surface form:
CLEOPATRA trial
|
oncology via predicate surface "therapeuticArea" ⓘ |
| APHINITY | HER2-positive early breast cancer via predicate surface "targetDisease" ⓘ |
| APHINITY | early-stage HER2-positive breast cancer via predicate surface "targetDisease" ⓘ |
| BioMarin Pharmaceutical | metabolic disorders via predicate surface "hasTherapeuticArea" ⓘ |
| BioMarin Pharmaceutical | lysosomal storage disorders via predicate surface "hasTherapeuticArea" ⓘ |
| BioMarin Pharmaceutical | skeletal dysplasias via predicate surface "hasTherapeuticArea" ⓘ |
| BioMarin Pharmaceutical | neurological rare diseases via predicate surface "hasTherapeuticArea" ⓘ |
| Abraxis BioScience | cancer via predicate surface "therapeuticArea" ⓘ |
| Abraxis BioScience | oncology via predicate surface "therapeuticArea" ⓘ |
| NantKwest | oncology via predicate surface "therapeuticArea" ⓘ |
| NantKwest | infectious diseases via predicate surface "therapeuticArea" ⓘ |
| NantKwest | autoimmune diseases via predicate surface "therapeuticArea" ⓘ |